ArticleMedeniyet medical journal2020

Aberrant SOCS3 Promoter Methylation as a Noninvasive Diagnostic Biomarker for Locally Advanced Prostate Cancer.

Berna Demircan Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.